Shuling Jiang
Director, 10% owner at Abvc Biopharma, Inc. (ABVC) since May 2022
Shuling Jiang has filed 1 insider report with the SEC since July 2022, as director and 10% owner at Abvc Biopharma, Inc. (ABVC). The latest filing, on July 12, 2022, is a Form 3: Shuling Jiang became an insider at Abvc Biopharma, Inc. (ABVC).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Shuling Jiang is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director, 10% ownersince May 2022 | $0.8663 | Jul 12, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Questions about Shuling Jiang
- What is Shuling Jiang's role at Abvc Biopharma, Inc.?
- Shuling Jiang reports to the SEC as director and 10% owner at Abvc Biopharma, Inc. (ABVC), according to the latest filing on July 12, 2022.
- Has Shuling Jiang bought or sold stock recently?
- No open-market purchases or sales by Shuling Jiang are on file.
- How do I get alerts when Shuling Jiang files?
- Follow Shuling Jiang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Shuling Jiang (SEC CIK 0001934554). Totals count each trade once, skipping amendments whose original is on file, from Jul 12, 2022 on. View on SEC EDGAR · Get this as JSON